- Home
- OSUR vs RXST Comparison
OSUR vs RXST Comparison
Compare OSUR & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OSUR | RXST |
|---|---|---|
| Founded | 2000 | 1997 |
| Country | United States | United States |
| Employees | N/A | 461 |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 275.4M | 232.2M |
| IPO Year | 2000 | 2021 |
Fundamental Metrics
Financial Performance| Metric | OSUR | RXST |
|---|---|---|
| Price | $4.35 | $5.61 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 10 |
| Target Price | $3.00 | ★ $9.78 |
| AVG Volume (30 Days) | 670.4K | ★ 1.3M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $167,064,000.00 | $134,479,000.00 |
| Revenue This Year | $4.48 | N/A |
| Revenue Next Year | $7.76 | $10.06 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.08 | $4.48 |
| 52 Week High | $4.58 | $13.22 |
Technical Indicators
Market Signals| Indicator | OSUR | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 58.92 | 56.40 |
| Support Level | $2.84 | $5.30 |
| Resistance Level | $4.58 | $6.53 |
| Average True Range (ATR) | 0.20 | 0.34 |
| MACD | -0.03 | 0.11 |
| Stochastic Oscillator | 59.65 | 94.64 |
Price Performance
Historical ComparisonAbout OSUR OraSure Technologies Inc.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.